Can-Fite BioPharma Ltd. (CANF) quarterly balance sheet — complete assets, liabilities & equity history
Can-Fite BioPharma Ltd. (CANF) balance sheet — 15-year assets, liabilities & shareholders' equity history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Total Current Assets | 8M | 8M | 9.44M | 9.44M | 7.62M | 7.62M | 8.98M | 8.98M | 5.83M | 5.83M | 9.91M | 9.06M | 10.91M | 13.38M | 9.16M | 12.56M | 14.59M | 17.67M | 20.07M | 14.47M |
| Cash & Short-Term Investments | 7.04M | 7.04M | 8.54M | 8.54M | 6.46M | 6.46M | 7.89M | 7.89M | 4.73M | 4.73M | 8.92M | 7.94M | 9.62M | 12.42M | 7.99M | 10.81M | 12.77M | 16.7M | 19.14M | 13.66M |
| Cash Only | 2.98M | 2.98M | 5.53M | 5.53M | 6.45M | 6.45M | 4.83M | 4.83M | 4.72M | 4.72M | 4.28M | 3.38M | 3.46M | 1.26M | 2.98M | 3.73M | 1.71M | 5.5M | 4.39M | 5.81M |
| Short-Term Investments | 4.06M | 4.06M | 3.01M | 3.01M | 2K | 2K | 3.06M | 3.06M | 9K | 9K | 4.64M | 4.56M | 6.16M | 11.15M | 5.01M | 7.09M | 11.05M | 11.2M | 14.75M | 7.86M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47K | 0 | 0 | 0 | 48K | 811K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.95 | - | - | - | 193.7 | 468.43 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -811K |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 74K | 74K | 0 | 0 | 1.09M | 77K | 0 | 0 | 78K | 1.12M | 1.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 52K | 52K | 74K | 74K | 96K | 96K | 138K | 138K | 94K | 94K | 81K | 105K | 123K | 110K | 126K | 141K | 157K | 174K | 185K | 165K |
| Property, Plant & Equipment | 52K | 52K | 74K | 74K | 96K | 96K | 138K | 138K | 94K | 94K | 81K | 105K | 123K | 110K | 126K | 141K | 157K | 174K | 185K | 165K |
| Fixed Asset Turnover | 1.94x | 1.60x | 1.37x | 1.19x | 1.05x | 0.86x | 1.30x | 1.54x | 1.68x | 1.81x | 1.67x | 1.72x | 1.68x | 1.66x | 1.48x | 1.37x | 1.23x | 1.14x | 1.17x | 1.72x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -105K | -123K | -110K | -126K | -141K | -157K | 0 | 0 | 0 |
| Total Assets | 8.05M | 8.05M | 9.51M | 9.51M | 7.72M | 7.72M | 9.12M | 9.12M | 5.92M | 5.92M | 9.99M | 9.17M | 11.03M | 13.49M | 9.28M | 12.71M | 14.75M | 17.85M | 20.25M | 14.64M |
| Asset Turnover | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.03x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x |
| Asset Growth % | 4.34% | 4.34% | 4.32% | 4.32% | 30.36% | 30.36% | -8.7% | -0.53% | -46.32% | -56.1% | 7.61% | -27.84% | -25.19% | -24.42% | -54.16% | -13.2% | 52.33% | 40.06% | 112.67% | 9.85% |
| Total Current Liabilities | 2.23M | 2.23M | 2.73M | 2.73M | 2.12M | 2.12M | 2.05M | 2.05M | 1.99M | 1.99M | 2.02M | 2.21M | 2.23M | 2.89M | 2.5M | 2.8M | 2.15M | 2.9M | 2.73M | 2.15M |
| Accounts Payable | 681K | 681K | 1.16M | 1.16M | 1.15M | 1.15M | 618K | 618K | 885K | 885K | 427K | 647K | 810K | 963K | 896K | 1.47M | 824K | 1.12M | 954K | 806K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 405K | 0 | 405K | 0 | 405K | 0 | 636K | 0 | 622K | 783K | 783K | 783K | 783K | 818K | 818K | 818K | 818K | 1M |
| Other Current Liabilities | 405K | 405K | 811K | 405K | 0 | 405K | 675K | 405K | 0 | 636K | 694K | 0 | 0 | 0 | 492K | 0 | 0 | 0 | 603K | 0 |
| Current Ratio | 3.60x | 3.60x | 3.46x | 3.46x | 3.60x | 3.60x | 4.38x | 4.38x | 2.93x | 2.93x | 4.90x | 4.10x | 4.89x | 4.63x | 3.66x | 4.49x | 6.78x | 6.09x | 7.35x | 6.72x |
| Quick Ratio | 3.60x | 3.60x | 3.46x | 3.46x | 3.60x | 3.60x | 4.38x | 4.38x | 2.93x | 2.93x | 4.90x | 4.10x | 4.89x | 4.63x | 3.66x | 4.49x | 6.78x | 6.09x | 7.35x | 7.10x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 975K | 975K | 1.19M | 1.19M | 1.42M | 1.42M | 1.63M | 1.63M | 1.46M | 1.46M | 1.73M | 1.72M | 1.93M | 2.1M | 2.31M | 2.48M | 2.7M | 2.92M | 3.14M | 3.15M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1K | 1K | 15K | 15K | 33K | 33K | 51K | 51K | 21K | 21K | 13K | 17K | 22K | 6K | 14K | 26K | 40K | 54K | 71K | 62K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.71M | -1.9M | -2.1M | -2.29M | -2.46M | -2.66M | -2.87M | -3.07M | -3.09M |
| Other Non-Current Liabilities | 974K | 974K | 0 | 1.18M | 0 | 1.38M | 0 | 1.58M | 0 | 1.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.2M | 3.2M | 3.92M | 3.92M | 3.54M | 3.54M | 3.68M | 3.68M | 3.44M | 3.44M | 3.75M | 3.93M | 4.16M | 5M | 4.81M | 5.28M | 4.85M | 5.82M | 5.87M | 5.3M |
| Total Debt | 49K | 49K | 71K | 71K | 90K | 90K | 104K | 104K | 57K | 57K | 40K | 51K | 66K | 48K | 62K | 74K | 87K | 109K | 124K | 102K |
| Net Debt | -2.94M | -2.94M | -5.46M | -5.46M | -6.36M | -6.36M | -4.72M | -4.72M | -4.66M | -4.66M | -4.24M | -3.33M | -3.39M | -1.22M | -2.92M | -3.65M | -1.63M | -5.39M | -4.27M | -5.7M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | -131.00x | -621.67x | - | - | -192.69x | - | -17.11x | -37.03x | -12.79x | - |
| Total Equity | 4.86M | 4.86M | 5.59M | 5.59M | 4.18M | 4.18M | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M | 5.24M | 6.87M | 8.49M | 4.47M | 7.43M | 9.89M | 12.02M | 14.38M | 9.33M |
| Equity Growth % | 16.04% | 16.04% | 2.87% | 2.87% | 68.78% | 68.78% | -12.93% | 3.84% | -63.94% | -70.81% | 39.6% | -29.52% | -30.51% | -29.37% | -68.91% | -20.42% | 150.11% | 69.88% | 136.78% | -2.17% |
| Book Value per Share | 1.31 | 1.31 | 0.02 | 2.59 | 0.37 | 0.37 | 0.64 | 0.64 | 0.41 | 0.41 | 1.26 | 1.28 | 1.68 | 2.16 | 1.64 | 2.73 | 3.64 | 4.42 | 6.49 | 5.11 |
| Total Shareholders' Equity | 4.86M | 4.86M | 5.59M | 5.59M | 4.18M | 4.18M | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M | 5.24M | 6.87M | 8.49M | 4.47M | 7.43M | 9.89M | 12.02M | 14.38M | 9.33M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60.65M | 60.65M | 60.65M | 60.65M | 43.72M |
| Retained Earnings | -180.79M | -180.79M | -176.19M | -176.19M | -171.24M | -171.24M | -166.36M | -166.36M | -162.44M | -162.44M | -158.48M | -156.83M | -155.07M | -153.4M | -150.85M | -147.83M | -145.3M | -143.11M | -140.67M | -133.97M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |